Troy New
Obstetrics & Gynecology · Grapevine, TXNPI 1962408062
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,200 of the $18,332 with a category attached, or 93.8%. Mimedx Group, Inc. accounts for 93.8% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $9,219, more than ten times the $283 reported in 2019. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $210.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$17K
- AbbVie$216
- Exeltis, USA Inc.$150
- Therapeuticsmd, Inc.$95
- AMAG Pharmaceuticals, Inc.$63
- Lupin Inc.$57
- plus $551 from 22 others
What the payments were for
- Consulting fees$17,20094%
- Food & beverage$1,0696%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 22 | $17,200 |
| AbbVie(2 entities) | 12 | $216 |
| Exeltis, USA Inc. | 9 | $150 |
| Therapeuticsmd, Inc. | 6 | $95 |
| AMAG Pharmaceuticals, Inc. | 5 | $63 |
| Lupin Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $39 |
| Agile Therapeutics, Inc. | 2 | $39 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Johnson & Johnson | 1 | $37 |
| Merck | 2 | $34 |
| Evofem Biosciences, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Avion Pharmaceuticals | 2 | $28 |
| Aspira Women's Health Inc | 2 | $26 |
| Myovant Sciences Inc. | 1 | $24 |
| Biogen | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $23 |
| Bayer | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Organon | 1 | $21 |
| Pfizer | 1 | $20 |
| Millicent US Inc | 1 | $20 |
| BD | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Channel Medsystems, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$1,200
How this compares
$18,332 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $168 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Grapevine
- Scott LauerGrapevine$52K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.